There are 2789 resources available
1194MO - Canakinumab (CAN) + docetaxel (DTX) for the second- or third-line (2/3L) treatment of advanced non-small cell lung cancer (NSCLC): CANOPY-2 phase III results
Presenter: Luis Paz-Ares
Session: Mini oral session - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
576MO - Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of <sup>177</sup>Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Presenter: Karim Fizazi
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
795MO - Pembrolizumab (pembro) in patients (pts) with microsatellite instability-high (MSI-H) advanced endometrial cancer (EC): Updated results from KEYNOTE-158
Presenter: David O'Malley
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Webcast
LBA26 - Darolutamide maintenance in metastatic castration resistant prostate cancer (mCRPC) previously treated with novel hormonal agents (NHA) and non-progressive disease after subsequent treatment with a taxane: A randomized double-blind placebo-controlled phase II trial (SAKK 08/16)
Presenter: Richard Cathomas
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
579MO - CheckMate 9KD cohort A2 final analysis: Nivolumab (NIVO) + rucaparib for chemotherapy (CT)-naïve metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Daniel Petrylak
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Yes
Presenter: Denis Soulieres
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
No
Presenter: Paolo Bossi
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Q&A
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast